Citadel Advisors’s Spectral AI MDAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-401,525
Closed -$3.95M 15223
2022
Q3
$3.95M Buy
401,525
+754
+0.2% +$7.42K ﹤0.01% 4273
2022
Q2
$3.93M Buy
400,771
+2,543
+0.6% +$24.9K ﹤0.01% 4247
2022
Q1
$3.89M Buy
398,228
+1,542
+0.4% +$15.1K ﹤0.01% 4668
2021
Q4
$3.9M Buy
396,686
+773
+0.2% +$7.58K ﹤0.01% 4804
2021
Q3
$3.84M Buy
395,913
+299,072
+309% +$2.9M ﹤0.01% 4835
2021
Q2
$935K Buy
+96,841
New +$940K ﹤0.01% 8540

Other funds holding MDAI

Citadel Advisors's MDAI Position: Q4 2022 in Review

Citadel Advisors sold out of Spectral AI (MDAI) in Q4 2022, closing a stake of 401,525 shares — an estimated $3.95M sold.

Citadel Advisors first reported a position in MDAI in Q2 2021 and held it in 6 quarters. The position peaked at $3.95M in Q3 2022. 11 funds tracked by Wall St. Rank hold MDAI as of Q4 2022.

  • Citadel Advisors reported no remaining Spectral AI position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 401,525 Spectral AI shares in Q4 2022, an estimated $3.95M.
  • Citadel Advisors first reported a position in Spectral AI in Q2 2021 and held it in 6 quarters.
  • Citadel Advisors's Spectral AI position peaked at $3.95M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Spectral AI as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.